Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08BCK
|
|||
Drug Name |
PMID26924192-Compound-24
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
KAINOS MEDICINE, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H19ClN4O4S
|
|||
Canonical SMILES |
CC1=NN=C2N1C3=C(C=C(C=C3)OC)C(=NC2COS(=O)(=O)C)C4=CC=C(C=C4)Cl
|
|||
InChI |
1S/C20H19ClN4O4S/c1-12-23-24-20-17(11-29-30(3,26)27)22-19(13-4-6-14(21)7-5-13)16-10-15(28-2)8-9-18(16)25(12)20/h4-10,17H,11H2,1-3H3/t17-/m0/s1
|
|||
InChIKey |
LELNYTXQJUOJKQ-KRWDZBQOSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bromodomain-containing protein 4 (BRD4) | Target Info | Inhibitor | [1] |
Target's Patent Info | Bromodomain-containing protein 4 (BRD4) | Target's Patent Info | [1] | |
WikiPathways | Chemical Compounds to monitor Proteins |
References | Top | |||
---|---|---|---|---|
REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.